HIV patients may ditch one drug without losing viral control
NCT ID NCT02302547
First seen Jan 04, 2026 · Last updated Jun 17, 2026 · Updated 25 times
Summary
This study tested whether people with HIV who have a low viral reservoir can safely switch from a three-drug regimen to a two-drug regimen (Truvada alone) while keeping the virus under control. The goal is to reduce long-term side effects and treatment costs. The trial involved 224 participants with well-controlled HIV and looked at viral load after 48 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de NANCY
Nancy, 54035, France
-
Centre de diagnostic et thérapeutique, Hopital Hotel Dieu
Paris, 94010, France
-
Consultation Maladies Infectieuses, Chu de Poitiers, Cedex
Poitiers, 86021, France
-
Hospital Tenon
Paris, 75970, France
-
Maladies Infectieuses, CHU de ROUEN
Rouen, 76031, France
-
Médecine Interne, Hôpital FOCH
Suresnes, 92151, France
-
Service Universitaire des Maladies Infectieuses et du Voyageur, CH DRON
Tourcoing, 59200, France
-
Service d'Immunologie Clinique centre de Vaccination anti- VIH ANRS Hopital Henri- Mondor
Créteil, 94010, France
-
Service de Medecine Interne et Maladies Infectieuses, CHRU BRETONNEAU, TOURS CEDEX9
Tours, 37044, France
-
Service de Médecine Interne et Maladies Infectieuses, Groupe Hospitalier La Rochelle, Cedex 01
La Rochelle, 17019, France
-
Service de Médecine Interne, CH de SAINTONGE- BP 326
Saintes, 17108, France
-
Service de Pneumologie, centre Hospitalier Fontenoy, CH de CHARTRES
Le Coudray, 28630, France
-
Service des Maladies Infectieuses et tropicales, APHP SAINT LOUIS
Paris, 75475, France
-
Service des Maladies Infectieuses, CHR Orléans La Source, ORLEANS CEDEX 2
CHR d'ORLEANS, 45067, France
-
Service des maladies Infectieuses et tropicales, CH GEORGES RENON
Niort, 79021, France
-
Unité des Maladies Infectieuses, CHU de CAEN
Caen, 14033, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.